Ma, Cheng-Jen
Chang, Tsung-Kun
Tsai, Hsiang-Lin
Su, Wei-Chih
Huang, Ching-Wen
Yeh, Yung-Sung
Chang, Yu-Tang
Wang, Jaw-Yuan http://orcid.org/0000-0002-7705-2621
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST107-2321-B-037-003, MOST107-2314-B-037-023-MY2)
Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH98-8G05, KMUH107-7R28, KMUH107-7R29, KMUH107-7R30, KMUH107-7M22, KMUH107-7M23)
Academia Sinica (Biosignature in Colorectal Cancers)
Article History
Received: 31 May 2019
Accepted: 18 November 2019
First Online: 19 December 2019
Ethics approval and consent to participate
: In compliance with the Helsinki Declaration, central ethical approval has been confirmed from the Institutional Review Board of Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan (ref. approval no. KMUHIRB-F (II) − 20190032) and we will not begin recruiting at other centers in the trial until local ethical approval has been obtained. Written informed consent will be obtained from each participant. The Additional file InternalRef removed summarizes the recommended items to address in a clinical trial protocol and related documents.
: Not applicable.
: The authors declare that they have no competing interests.